Back to Search
Start Over
Complete hepatitis B virus genome analysis in chronically infected children before and during lamivudine treatment
- Source :
- Journal of Medical Virology. 77:194-202
- Publication Year :
- 2005
- Publisher :
- Wiley, 2005.
-
Abstract
- It is well established that during lamivudine treatment, mutations emerge within the polymerase gene but there is little information about the selection of other mutations in the whole hepatitis B virus (HBV) genome. The aim of this study was to investigate whether mutations outside this region are selected during lamivudine treatment. The complete HBV genomes of six HBsAg positive chronically infected children were isolated from the children's sera before, at the beginning and during lamivudine treatment, amplified and sequenced directly. A change in the mutation rate and type in periods with and without treatment for one and the same patient were examined longitudinally because blood samples were taken long before treatment started. During the testing period before treatment, 12 mutations occurred within 11.7 ± 8.1 months in all genomes, resulting in a mutation rate of 1.1 × 10−3 substitutions per site per year. During treatment with lamivudine, 20 mutations occurred in all patients within an average period of 7.6 ± 1.2 months, giving an average mutation rate of 1.8 × 10−3 substitutions per site per year. The 20 mutations observed during the treatment period occurred in only 4 of the patients and only 3 patients experienced nonsense mutations during lamivudine treatment. The mutations were spread across the entire genome with a non-significant cluster during treatment in the P-ORF (18 mutations vs. 7, P = 0.073) and S-ORF (11 vs. 2, P = 0.063). Mutations causing drug resistance did not emerge. This study describes the changes in the complete HBV genome in the spontaneous course of infection and during lamivudine treatment. An increased mutation rate and the occurrence of specific mutations could not be proven for the early phase of lamivudine treatment. J. Med. Virol. 77:194–202, 2005. © 2005 Wiley-Liss, Inc.
- Subjects :
- Male
Hepatitis B virus
Mutation rate
HBsAg
Genes, Viral
Nonsense mutation
Mutation, Missense
Biology
medicine.disease_cause
Antiviral Agents
Drug Administration Schedule
Virus
Hepatitis B, Chronic
Orthohepadnavirus
Virology
medicine
Humans
Child
Lamivudine
biology.organism_classification
Infectious Diseases
Amino Acid Substitution
Hepadnaviridae
Carrier State
Immunology
Female
medicine.drug
Subjects
Details
- ISSN :
- 10969071 and 01466615
- Volume :
- 77
- Database :
- OpenAIRE
- Journal :
- Journal of Medical Virology
- Accession number :
- edsair.doi.dedup.....9ab99a935a4532d1ff369f74e9a6a548